Emerging RAS-directed therapies for cancer

RAS oncogenes are the most commonly mutated oncogenes in human cancer, and RAS-mutant cancers represent a major burden of human disease. Though these oncogenes were discovered decades ago, recent years have seen major advances in understanding of their structure and function, including the therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, Michael, Cowzer, Darren, Kolch, Walter, Duffy, Austin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094076/
https://www.ncbi.nlm.nih.gov/pubmed/35582302
http://dx.doi.org/10.20517/cdr.2021.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094076/
https://www.ncbi.nlm.nih.gov/pubmed/35582302
http://dx.doi.org/10.20517/cdr.2021.07

Ejemplares similares